X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Chemo-Pharma Laboratories Ltd.
BSE CODE: 506365   |   NSE CODE: NA   |   ISIN CODE : INE320M01019   |   14-Aug-2025 Hrs IST
BSE NSE
Rs. 131.00
-3.9 ( -2.89% )
 
Prev Close ( Rs.)
134.90
Open ( Rs.)
128.20
 
High ( Rs.)
141.50
Low ( Rs.)
128.20
 
Volume
5192
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
14-Aug-2025 22-Aug-2025 Inter alia, to consider and approve:- (1) the request letter dated 11th August, 2025 received for reclassification of the status by Ms. Shanta Somani from Promoter Group Shareholder to Public Shareholder pursuant to Regulation 31A of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 subject to the requisite approvals from the Stock exchanges and any other necessary approval(s).
05-Aug-2025 12-Aug-2025 A.G.M. & Quarterly Results Inter alia, to consider and approve:- 1. To consider the proposal for change of Name of the Company. 2. To consider the proposal to change the Main Object of the Company & alteration in Object Clause of Memorandum of Association of the Company. 3. To consider the proposal for shifting of the Registered Office of the Company from the State of Maharashtra to State of Gujarat.
28-Jul-2025 31-Jul-2025 Inter alia, to consider and approve:- 1. To consider and accept resignation of existing statutory auditors. 2. To appoint fresh statutory auditors to fill the casual vacancy cause due to resignation of existing statutory auditor.
14-May-2025 29-May-2025 Audited Results
08-Apr-2025 16-Apr-2025 Inter alia, to consider and approve : 1. To consider and approve appointment Shri. Ruchit Mehta (Din: 8810586) as an Additional Director of the Company to be designated as Managing Director and Chief Executive Officer of the Company subject to approval of Shareholder of the Company. 2. To consider and approve appointment Shri. Utsav Trivedi (Din:10720143) as an Additional Director of the Company to be designated as Chief Financial Officer of the Company subject to approval of Shareholder of the Company. 3. To consider and approve appointment Ms. Sarvagya Goel (Din: 10622443) as an Additional Director of Company to be designated as Non-Executive Independent Director of the Company subject to approval of Shareholder of the Company. 4. To consider and approve appointment Ms. Shilpi Chopra (Din: 07161915) as an Additional Director of Company to be designated as Non-Executive Independent Director of the Company subject to approval of Shareholder of the Company. 5. To consider and approve appointment CS Bhawna Rajput (ACS-72357) as Company Secretary and Compliance Officer of the Company. 6. To place on record the Resignation Letter submitted by Mr. Bhavin Sheth who has tendered his resignation from the position of Executive Director and Chief Executive Officer of the Company.
13-Jan-2025 27-Jan-2025 Quarterly Results
15-Oct-2024 28-Oct-2024 Quarterly Results
09-Jul-2024 29-Jul-2024 A.G.M. & Quarterly Results
10-May-2024 27-May-2024 Audited Results
09-Jan-2024 29-Jan-2024 Quarterly Results Inter alia, to consider and approve the Re-Appointment of M/s Kavita Khatri & Associates Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2023-24.
Page 1 of 7
PREV || NEXT